The purpose of the Great Lakes Drug Metabolism Discussion Group (GLDMDG) is to facilitate interactions among scientists interested in all aspects of drug metabolism and disposition. In its fourth year of existence, the GLDMDG organizes meetings to promote the collegial exchange of ideas on current topics of interest to its members. Learn more...
2009 Meeting Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Sponsor & Exhibitor Opportunities
Download the 2009 GLDMDG Meeting Sponsor/Exhibitor Prospectus
Contact:
Anna Talyor
(734) 764-8165
annat@umich.edu
Your company also can become a meeting sponsor by completing the online registration form.
Speaker / Program Ideas
Have a suggestion for a speaker or topic at a future GLDMDG meeting? Send an email to: greatlakesdmdg@gmail.com
About the GLDMDG
Stay Connected
Related Links
American Association of Pharmaceutical Scientists (AAPS)
International Society for the Study of Xenobiotics (ISSX)
Delaware Valley Drug Metabolism Discussion Group
New England Drug Metabolism Discussion Group
North Jersey ACS Drug Metabolism Discussion Group
Research Triangle Park Drug Metabolism Discussion Group
Online Registration Closed
Online registration is now closed for the 4th annual meeting. On-site registration will not be available.
Meeting Schedule
Thursday, April 30, 2009
Registration, coffee and poster setup, 10:00 AM
Welcome, 11:00 AM
Chemically reactive metabolites in drug discovery and development – Should we care?, 11:10 AM
Thomas Baillie, University of Washington.
Metabolism and DNA binding of carcinogenic tobacco-specific nitrosamines., 11:50 AM
Stephen Hecht, University of Minnesota.
Lunch, poster viewing, and sponsor booths, 12:30 PM
Structure/function analysis of human CYP2A enzymes and the relationship to lung cancer., 2:00 PM
Emily Scott, University of Kansas.
Using a drug metabolism approach to predict response in breast cancer patients., 2:40 PM
James Rae, University of Michigan.
Break, 3:20 PM
Investigation of the metabolism of natural product chemoprevention agents using ultrafiltration mass spectrometry.. 4:00 PM
Richard van Breemen, University of Illinois at Chicago.
Improving warfarin dosing through genetic testing., 4:40 PM
James Burmester, Marshfield Clinic.
Poster session (author available), sponsor booths, and mixer, 5:20 PM
Dinner, 7:30 PM
Friday, May 1, 2009
Business meeting for organizing committee members., 7:30 AM
Coffee., 8:00 AM
PK and PK/PD modeling and simulation in drug discovery., 9:00 AM
Robert Carr, Abbott Laboratories.
Models for incorporating glucuronidation into human pharmacokinetic predictions., 9:35 AM
Hongliang Cai, Pfizer.
Break, 10:10 AM
The effect of losing multiple clearance pathways on drug safety and viability., 10:40 AM
Shelby Anderson, Lilly Research Labs.
Facile hepatic uptake assays to support drug discovery and development., 11:15 AM
Daniel Bow, Abbott Laboratories.
Closing remarks, 11:50 AM
4th Annual Meeting
The 4th annual meeting of the Great Lakes Drug Metabolism Discussion Group will be held on April 30th and May 1st, 2009 at the Lincolnshire Marriott® Resort in Lincolnshire, Illinois.
To reserve a room at the group rate of $129.00 per night, navigate to the Lincolnshire Marriott® Resort web site and enter the group code "dmmdmma".